id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-N-0500-0004,FDA,FDA-2008-N-0500,"Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Requirements on Content and Format of Labeling for Human Prescription Drug and 
Biological Products",Notice,30 Day Proposed Information Collection,2015-05-29T04:00:00Z,2015,5,2015-05-29T04:00:00Z,2015-06-30T03:59:59Z,2015-05-29T13:09:10Z,2015-12957,0,0,0900006481b0d10f
FDA-2008-N-0500-0003,FDA,FDA-2008-N-0500,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Requirements on Content and Format of Labeling for
Human Prescription Drug and Biological Products",Notice,60 Day Proposed Information Collection,2015-01-21T05:00:00Z,2015,1,2015-01-21T05:00:00Z,2015-03-24T03:59:59Z,2015-03-24T02:08:51Z,2015-00761,0,0,09000064819d54c5